We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+2.44%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$542B
AUM Growth
+$18.5B
Cap. Flow
+$17.7B
Cap. Flow %
3.26%
Top 10 Hldgs %
22.88%
Holding
3,563
New
62
Increased
2,296
Reduced
842
Closed
70

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$793M
2
MSFT icon
Microsoft
MSFT
+$777M
3
KO icon
Coca-Cola
KO
+$755M
4
AAPL icon
Apple
AAPL
+$744M
5
NVDA icon
NVIDIA
NVDA
+$718M

Sector Composition

Rank Sector Weight
1 Technology 23.59%
2 Financials 12.77%
3 Consumer Discretionary 9.88%
4 Healthcare 9.85%
5 Industrials 8.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XPL icon
3476
Solitario Resources
XPL
$67.5M
$26.7K ﹤0.01%
44,899
USIO icon
3477
Usio Inc
USIO
$59.1M
$26K ﹤0.01%
17,787
RAVE icon
3478
RAVE Restaurant Group
RAVE
$44.1M
$25.6K ﹤0.01%
10,012
CTMX icon
3479
CytomX Therapeutics
CTMX
$714M
$25.6K ﹤0.01%
24,817
IMUX icon
3480
Immunic
IMUX
$191M
$25K ﹤0.01%
2,500
WWR icon
3481
Westwater Resources
WWR
$52.1M
$24.4K ﹤0.01%
34,475
LYRA
3482
DELISTED
LYRA THERAPEUTICS INC
LYRA
$23K ﹤0.01%
2,232
FARM
3483
DELISTED
Farmer Brothers
FARM
$21.2K ﹤0.01%
11,781
SUP
3484
DELISTED
Superior Industries International
SUP
$21.1K ﹤0.01%
10,350
IMA
3485
ImageneBio Inc
IMA
$67.2M
$20.2K ﹤0.01%
1,025
+19
+2% +$384
SKYX icon
3486
SKYX Platforms
SKYX
$149M
$19.5K ﹤0.01%
16,813
CLSD
3487
DELISTED
Clearside Biomedical
CLSD
$19.2K ﹤0.01%
1,348
UONE icon
3488
Urban One Class A
UONE
$22.8M
$18.8K ﹤0.01%
1,224
SLS icon
3489
SELLAS Life Sciences
SLS
$2.02B
$16.9K ﹤0.01%
16,238
HYFM icon
3490
Hydrofarm Holdings
HYFM
$2.82M
$15.7K ﹤0.01%
2,715
JOB icon
3491
GEE Group
JOB
$22.7M
$13.8K ﹤0.01%
66,522
OESX icon
3492
Orion Energy Systems
OESX
$40.3M
$13.6K ﹤0.01%
1,699
CDT icon
3493
CDT Equity Inc
CDT
$1.69M
0
ABAT icon
3494
American Battery Technology Co
ABAT
$278M
-32,528
Closed -$34.8K
ASRT
3495
DELISTED
Assertio
ASRT
-2,676
Closed -$47.4K
BGFV
3496
DELISTED
Big 5 Sporting Goods
BGFV
-12,375
Closed -$25.9K
CTXR icon
3497
Citius Pharmaceuticals
CTXR
$17.4M
-3,043
Closed -$38.1K
CVM icon
3498
CEL-SCI Corp
CVM
$21.3M
-549
Closed -$17.5K
DPZ icon
3499
Domino's
DPZ
$11.7B
-229,099
Closed -$98.5M
KYNB
3500
Kyntra Bio
KYNB
$27.5M
-2,321
Closed -$23.2K

Similar funds

Charles Schwab's Q4 2024 Portfolio in Review

As of Q4 2024, Charles Schwab held 3,563 positions worth $542B, up 3.5% from $524B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Charles Schwab deployed $17.7B of net new capital in Q4 2024, opening 62 new positions and adding to 2,296 existing holdings. Its largest new stake was Janus Henderson AAA CLO ETF: 3,465,261 shares worth $176M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Vanguard Mortgage-Backed Securities ETF, an estimated $247M trimmed.

  • Charles Schwab's largest Q4 2024 buy was Janus Henderson AAA CLO ETF: 3,465,261 shares worth $176M.
  • Charles Schwab added most to Amgen in Q4 2024, an estimated $793M increase.
  • Charles Schwab's biggest Q4 2024 reduction was Vanguard Mortgage-Backed Securities ETF, cutting an estimated $247M.
  • Charles Schwab fully exited Vanguard Real Estate ETF in Q4 2024, selling an estimated $251M.
  • Charles Schwab's ten largest holdings make up 23% of its $542B portfolio in Q4 2024.
  • Charles Schwab opened 62 new positions and closed 70 in Q4 2024.
  • Charles Schwab's portfolio value rose 3.5% quarter-over-quarter to $542B.

Based on Charles Schwab's 13F filing for Q4 2024, filed 6 Feb 2025.